News

Job: Research & Project Officer, Committee for Melbourne

About the Committee Committee for Melbourne is all about shaping a better future for Melbourne. Working together with our members, we make a difference by challenging the status quo and encouraging thought leadership to create change through confident and…

Job: Head of Drug Discovery, Adalta Limited

The Company AdAlta Limited (ASX:1AD) is a drug discovery and development company using its powerful technology platform to generate a promising new class of protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The…

Job: Business Development Associate – Regional Trials Network

Grow the Cancer Clinical Trials Portfolio in Regional Victoria Part-time (0.8 FTE) Attractive remuneration package 12-month contract, with the possibility of extension Located in the Victorian Comprehensive Cancer Centre (VCCC) Building in Parkville, Cancer Trials Australia (CTA) is a…

Women Leading World-Class Health Innovation in Melbourne

Victoria grows globally competitive innovation-intensive companies. Innovation is a people-driven process that thrives on diverse thinking and views. Now that business is embracing the performance-based argument, successful women in and those aspiring towards leadership roles need recognition to…

Australia is backing health innovation industries to build future economy

Announced in the federal budget last night, the 21st century National Medical Industry Growth Plan will deliver $1.3 billion to support Australia as a global health innovation leader in medical technology, biotechnology and pharmaceuticals while improving health outcomes for…

Job: Project Manager | ASX Biotech

• New opportunity • Project Management • Drug Development | CMC Our Client Our client is an ASX listed clinical stage biotechnology company moving into an exciting and active time. Recent successful clinical trials have shown the technology…

New BioMelbourne Network Board Appointment – David Herd

The BioMelbourne Network Board was delighted to welcome David Herd as new Board Director at the most recent board meeting.  “BioMelbourne is a very active and positive contributor to shaping many aspects of our Industry and I am…

BioMelbourne Network gives State Budget 6/10 for the health innovation industry

BioMelbourne Network CEO Dr Krystal Evans welcomes the State Government of Victoria’s Budget yesterday, noting the significant investment in digital infrastructure, the Heart Hospital and the ongoing operational support for the Melbourne Biomedical Precinct. However, these initiatives are…

BioMelbourne Network Policy Principles – 2018 State Election

The biotechnology, medical technology and pharmaceutical sector in Victoria is vibrant and growing but yet to reach its full potential contribution to the Victorian economy. Historical support from governments has allowed the sector to grow, now employing 75,000…

AusBiotech announces leadership changes

Mr Glenn Cross retires as AusBiotech’s CEO, and Ms Lorraine Chiroiu appointed as new CEO effective early July 2018 Mr Glenn Cross retirement AusBiotech Chairman, Julie Phillips, has tonight announced that Mr Glenn Cross has decided to retire…

Job: Director, Clinical Operations & Medical Affairs

Prota Therapeutics is an Australian private company developing immunotherapy based treatments for food allergy. The company’s lead product based on technology licensed from the Murdoch Children’s Research Institute, is under development as a treatment for the most common…

Home

News & opinion

Member Directory

Events